Pseudomonas an update

82
Pseudomonas an update Dr.T.V.Rao MD Dr.T.V.Rao MD 1

description

Pseudomonas an update

Transcript of Pseudomonas an update

Page 1: Pseudomonas  an  update

Pseudomonasan update

Dr.T.V.Rao MD

Dr.T.V.Rao MD 1

Page 2: Pseudomonas  an  update

What are Pseudomonas • Pseudomonads are aerobic, saprophytic

and innately resistant bacteria causing opportunist infections in man, animals, plants and insects. The most important pseudomonad species responsible for human infections are Pseudomonas aeruginosa, Burkholderia pseudo mallei and members of the Burkholderia cepacia complex.Dr.T.V.Rao MD 2

Page 3: Pseudomonas  an  update

Pseudomonas

Dr.T.V.Rao MD 3

• A large group of aerobic, non sporing gram negative bacteria motile by polar flagella

• Found In nature water, soil, other moist environments

• Some of them are pathogenic to plants• Creation of new genera such as

Burkholderia. Stenotrophomnonas

Page 4: Pseudomonas  an  update

Pseudomonas aeruginosa

• Gram-negative aerobe bacteria

• Commonly found in the environment– At any moist location

• Common cause of nosocomial infections

Dr.T.V.Rao MD 4

Page 5: Pseudomonas  an  update

- Widely distributed in soil and water

- Gram negative rods- Aerobic- Motile- Produce water-

soluble pigments• Opportunistic

pathogens

General Characteristics

Dr.T.V.Rao MD 5

Page 6: Pseudomonas  an  update

Pseudomonas • Aerobic,

opportunistic pathogen

• Gram-negative bacillus

• FlagellatedDr.T.V.Rao MD 6

Page 7: Pseudomonas  an  update

Structure of Pseudomonas

Dr.T.V.Rao MD 7

Page 8: Pseudomonas  an  update

Pseudomonas aeruginosa

•Morphologyslender, Gram negative bacillussize-1.5 microns-3*1.5micronsmotile by polar flagellanon capsulated though some mucoid

strains may sometimes occursome are pilated

Dr.T.V.Rao MD 8

Page 9: Pseudomonas  an  update

Morphology

Dr.T.V.Rao MD 9

• They are slender gram negative bacillus, 1.5 – 3 microbes x 0.5 microns

• Monoflgellar ?• Non capsulated but many strains have mucoid

slime layer• Isolates from Cystic fibrosis patients have

abundance of extracellular polysaccharides composed of alginate polymers

• Escape the defence mechanisms by loose capsule in which micro colonies of bacillus are enmeshed and protected from host defences.

Page 10: Pseudomonas  an  update

Cultural characteristicsObligate aerobeWide range of temperature

5°c-42°c optimum 37°cOrdinary media – large, opaque, irregular, with

distinctive musty, mawkish, earthy smell

Dr.T.V.Rao MD 10

Page 11: Pseudomonas  an  update

P. aeruginosaForms round colonies with a fluorescent greenish color, sweet odor, and b-hemolysis.

Pyocyanin- nonfluorescent bluish pigment;

pyoverdin- fluorescent greenish pigment;

pyorubin, and pyomelanin

Some strains have a prominent capsule (alginate).

Identification of P. aeruginosa is usually based on oxidase test

and its colonial morphology: b-hemolysis, the presence of

characteristic pigments and sweet odor, and growth at 42 oC. Dr.T.V.Rao MD 11

Page 12: Pseudomonas  an  update

Cultural Characters

Dr.T.V.Rao MD 12

• Obligate aerobe, but grow anaerobically if nitrate is available

• Growth occurs at wide range of temperatures 6-42 c the optimum being 37 c

• Growth on ordinary media producing large opaque irregular colonies with distinctive musty mawkish or earthy smell.

• Iridescent patches with metallic sheen are seen in cultures on nutrient agar.

• In broth forms dense turbidity with surface pellicle.

Page 13: Pseudomonas  an  update

Motile (by single or multiple polar flagella) gram-negative rods

Obligate (strict) aerobes (most strains)

Oxidase (usually) and catalase positive

Nonfermentative chemoheterotrophic respiratory metabolism

Characteristics of Pseudomonas aeruginosa

Dr.T.V.Rao MD 13

Page 14: Pseudomonas  an  update

Characteristics of Pseudomonas

• Minimal nutritional requirements .; Many organic compounds used as C and N sources, but only a few carbohydrates by oxidative metabolism

• Glucose used oxidatively• Lactose negative on MacConkey agar

Dr.T.V.Rao MD 14

Page 15: Pseudomonas  an  update

Nutrient agar-Cont..

• Nutrient agar- Colonies are

smooth,large,translucent,low convex,2-4mm in diameter.

Produce sweetish aromatic odor

Greenish blue pigment diffuses

Dr.T.V.Rao MD 15

Page 16: Pseudomonas  an  update

Growing on • Blood agarSimilar to nutrient agar Many are haemolytic• Mac conkey agarColourless,non lactose fermenters• Cetrimide agar selective media

Dr.T.V.Rao MD 16

Page 17: Pseudomonas  an  update

Pigment Production

Dr.T.V.Rao MD 17

Some strains produce diffusible pigments: • Pyocyanin (blue); fluorescein

(yellow); pyorubin (red) P. aeruginosa produces characteristic

grape-like odor and blue-green pus & colonies

Broad antibiotic resistance

Page 18: Pseudomonas  an  update

• Toxic extracellular products in culture filtrates

• Exotoxin A and S• Exotoxin A acts as

NADase resembling Diphtheria toxin

• Proteases,elastatese hemolysins and enterotoxin

• Slime layer and Biofilms

Toxins and enzymes in pseudomonas

Dr.T.V.Rao MD 18

Page 19: Pseudomonas  an  update

Biochemical reactions

Dr.T.V.Rao MD 19

• Oxidative and Non fermentative• Glucose is utilized oxidatively• Indole, MR and VP and H2 S tests

are negative• Catalase, Oxidase, and Arginine

tests are positive

Page 20: Pseudomonas  an  update

Typing and Importance

Dr.T.V.Rao MD 20

• Important cause of Hospital Infections• Important for epidemiological purpose• Serotyping• Bacteriocins typing• Pyocyanin• Aeruginosa typing• Restriction endonuclease typing with pulsed

gel electrophoresis

Page 21: Pseudomonas  an  update

Resistance

Dr.T.V.Rao MD 21

• Killed at 55oc in on 1 hour• High resistance to chemical agents• Resistance to quaternary ammonium

compounds.Chlorxylenol• Resistant to Hexachlorophenes• Grows also in antiseptic bottles• Dettol as Cetrimide as selective medium• Sensitive to acids silver salts, beta glutaraldehyde

Page 22: Pseudomonas  an  update

Major Pathogenicity

Dr.T.V.Rao MD 22

• Blue pus• Causing the nosocomial infection• Suppurative otitis • Localised and generalised infections• Urinary tract infection after catheterization• Iatrogenic meningitis• Post tracheostomy pulmonary infections

Page 23: Pseudomonas  an  update

Pathogenesis and Immunity

Dr.T.V.Rao MD 23

• P. aeruginosa can infect almost any external site or organ.

• P. aeruginosa is invasive and toxigenic. It attaches to and colonizes the mucous membrane or skin, invade locally, and produces systemic diseases and septicemia.

• P. aeruginosa is resistant to many antibiotics. It becomes dominant when more susceptible bacteria of the normal flora are suppressed.

Page 24: Pseudomonas  an  update

• Septicaemia• Endocarditis• Ecthyma gangrenous• Infantile diarrhoea• Shanghai fever• Disabling eye

infections• Survive with minimal

nutrients

Clinical Presentations

Dr.T.V.Rao MD 24

Page 25: Pseudomonas  an  update

P. aeruginosa infections• P. aeruginosa infections are of

particular concern for Cystic fibrosis patients

• Burn patients• Hospitalised patients

–Case mortality rate for patients infected with P. aeruginosa approaches 50%

Dr.T.V.Rao MD 25

Page 26: Pseudomonas  an  update

Pseudomonas aeruginosa an important opportunistic pathogen

Dr.T.V.Rao MD 26

• Pseudomonas aeruginosa is an opportunistic pathogen, meaning that it exploits some break in the host defences to initiate an infection. In fact, Pseudomonas aeruginosa is the epitome of an opportunistic pathogen of humans. The bacterium almost never infects uncompromised tissues, yet there is hardly any tissue that it cannot infect if the tissue defences are compromised in some manner

Page 27: Pseudomonas  an  update

P. aeruginosa is an opportunistic pathogen

• Extremely broad host spectrum• Hardly any infections in the normal human host• Severe immunodeficiencies and medical devices

predispose the patients to P. aeruginosa infections• Broad spectrum of clinical symptoms

– Urinary tract infections – Pulmonary infections– Soft tissue infections– Sepsis– Bone and joint infections– Endocarditis

Dr.T.V.Rao MD 27

Page 28: Pseudomonas  an  update

P,aeroginosa is an opportunistic pathogen

Dr.T.V.Rao MD 28

• P,aeroginosa is an opportunistic pathogen. It rarely causes disease in healthy persons. In most cases of infection, the integrity of a physical barrier to infection (eg, skin, mucous membrane) is lost or an underlying immune deficiency (eg, neutropenia, immunosuppression) is present. Adding to its pathogenicity, this bacterium has minimal nutritional requirements and can tolerate a wide variety of physical conditions

Page 29: Pseudomonas  an  update

WHO are MORE SUSCEPTIBLE TO INFECTION

Dr.T.V.Rao MD 29

• This bacterium is of particular concern to individuals with cystic fibrosis who are highly susceptible to pseudomonas lung infections. Pseudomonas aeruginosa is also of grave concern to cancer and burn patients as well as those people who are immunocompromised. The case fatality rate for individuals infected with Pseudomonas aeruginosa approaches 50 percent.

Page 30: Pseudomonas  an  update

Nosocomial infections• Fourth most common isolated nosocomial

pathogen accounting for approx. • 10 % of all hospital acquired infections.• Patient-to-patient spread and direct patient

contact with environmental reservoirs– disinfectants, – respiratory equipment, – food, – sinks, taps

Dr.T.V.Rao MD 30

Page 31: Pseudomonas  an  update

Pseudomonas prominent hospital acquired infections

Dr.T.V.Rao MD 31

• It causes urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteraemia, bone and joint infections, gastrointestinal infections and a variety of systemic infections, particularly in patients with severe burns and in cancer and AIDS patients who are immunosuppressed.

Page 32: Pseudomonas  an  update

Virulence Factors (structural components)

• “Alginate”• Adherence proteins and “pili• Lipopolysaccharide (LPS)• Pyocyanin

Virulence factors

Dr.T.V.Rao MD 32

Page 33: Pseudomonas  an  update

• Respirators• Endotracheal

tubes• Can be Infected • All equipment's

to be sterilized

Infection of Equipment's

Dr.T.V.Rao MD 33

Page 34: Pseudomonas  an  update

• Pseudomonas aeruginosa is the most frequently encountered lung pathogen in patients with cystic fibrosis (CF). Following initial, often intermittent, episodes of infection, it becomes a permanently established component of the chronically infected lung in more than 80% of patients and confers an adverse prognosis

Pseudomonas and Cystic fibrosis

Dr.T.V.Rao MD 34

Page 35: Pseudomonas  an  update

Pigment production• Pyocyanin

Bluish green phenazine pigment Soluble in chloroform and waterNot produced by other species

• Pyoverdin(fluorescein)It is a greenish yellow pigment Insoluble in chloroform but soluble in waterProduced by many other species

Dr.T.V.Rao MD 35

Page 36: Pseudomonas  an  update

Pyocyanin Pyoverdin

Dr.T.V.Rao MD 36

Page 37: Pseudomonas  an  update

Cont..• PyorubinReddish brown pigment Insoluble in chloroform but soluble in

water• pyomelaninBrown to black pigmentProduction is uncommon

Dr.T.V.Rao MD 37

Page 38: Pseudomonas  an  update

Biochemical reactionsO/F test-

oxidativeCatalase-

positiveOxidase-positiveNitrate

reduction-positive Dr.T.V.Rao MD 38

Page 39: Pseudomonas  an  update

Biochemical Tests• Indole test-negative• Methyl red test-

negative• Vp test-negative• Citrate test-positive• Urease test-negative

Dr.T.V.Rao MD 39

Page 40: Pseudomonas  an  update

Structural Components• Adherence to host cells mediated by pili and nonpilus

adhesins. • LPS (lipopolysaccharide) inhibiting antibiotic killing

and suppress neutrophil and lymphocyte activity• Alginate – mucoid exopolysaccharide that forms a

shiny biofilm protecting from antibodies, complement, phagocytosis, and antibiotics

• Procyanin – impairs ciliary function, mediates tissue damage through production of oxgen radicals

Dr.T.V.Rao MD 40

Page 41: Pseudomonas  an  update

Patho mechanisms• Adhesion

– Pile, flagella and fimbriae• Invasion

– Extracellular enzymes and toxins (proteases, elastase, phospholipases, rhamnolipids, Exotoxin A)

• Dissemination– Leukocidin inhibits neutrophils und leukocytes– LPS (Endotoxin)

• Protection– Capsule (Alginate)

Dr.T.V.Rao MD 41

Page 42: Pseudomonas  an  update

PathogenesisVirulence Factors (toxins and enzymes):

• Exotoxin A• Exoenzyme S• Endotoxins• Phospholipase C• Elastase and Alkaline Protease

Dr.T.V.Rao MD 42

Page 43: Pseudomonas  an  update

PATHOGENESIS• Important agent in causing nosocomial

infections• Most common infections are Urinary tract infections following

catheterizationAcute purulent meningitis following lumbar

puncturePost-tracheostomy pulmonary infectionSepticemia in debilitated patients

Dr.T.V.Rao MD 43

Page 44: Pseudomonas  an  update

Mechanism Of Pathogenesis

• Caused by exotoxins,proteases,elastases,haemolysins,lipases and enterotoxins

Exotoxin A-lethal toxinElastases-haemorrhagic lesions Enterotoxins-diarrhoeal diseaseSlime layer acts as a capsule and enhances

virulence

Dr.T.V.Rao MD 44

Page 45: Pseudomonas  an  update

Exotoxin A• Similar in structure to Diphtheria toxin • Inhibits protein synthesis by ADP-ribosylating

EF-2 (G-protein)• Causes Dermatonecrosis in burn wounds,

corneal damage in ocular infections, and tissue damage in chronic pulmonary infections.

• Also this toxin is immunosuppressive• ADP-ribosylates G-proteins including p21 RAS

interfering with host cell growthDr.T.V.Rao MD 45

Page 46: Pseudomonas  an  update

Phospholipase C

• Heat labile hemolysins• Breaks down lipids and

lecithin causing tissue destruction

• Stimulates inflammatory response Dr.T.V.Rao MD 46

Page 47: Pseudomonas  an  update

Lactase and Alkaline Protease

• Destruction of elastin-containing tissues (blood vessels, lung tissue, skin), collagen, immunoglobulin's, and complement factors

• Can produce hemorrhagic lesions (ecthyma gangrenous) associated with disseminated infection

• Inactivation of interferon and TNF-AlphaDr.T.V.Rao MD 47

Page 48: Pseudomonas  an  update

Epidemiology• Ubiquitous in moist environmental sites

in the hospital as well as nature• No seasonal incidence• Can transiently colonize the respiratory

and GI tract of hospitalized patients• Minimal nutritional requirements and

can tolerate broad temperature spectrum

Dr.T.V.Rao MD 48

Page 49: Pseudomonas  an  update

Important cause of Hospital Acquired Infection

• Pseudomonas aeruginosa is an important cause of hospital-acquired infections, especially in intensive care units and in neutropenic patients. Infections range from topical to systemic and may be trivial or life-threatening.

Dr.T.V.Rao MD 49

Page 50: Pseudomonas  an  update

Clinical Disease• Pulmonary Infections• Burn Wound Infections and other skin

and soft tissue infections (life threatening)

• UTI’s (especially catheterized)• External Otitis (malignant OE, swimmer’s

ear)• Eye Infections and corneal ulceration via

contaminated contact lens cleaning fluids• Pseudomonal Endocarditis

Dr.T.V.Rao MD 50

Page 51: Pseudomonas  an  update

Pulmonary Infections• Can range from asymptomatic colonization to severe

necrotizing bronchopneumonia• Colonization is seen in patients with cystic fibrosis,

chronic lung disease, and neutropenia• Mucoid strains are commonly isolated from chronic

pulmonary patients and are more difficult to eradicate

• Predisposing conditions include previous therapy with broad spectrum abx (disrupts normal protective bacteria population and use of respiratory therapy equipment (can introduce the organism to lower airways)

• Mortality rate can be as high as 70% for invasive bronchopneumonia Dr.T.V.Rao MD 51

Page 52: Pseudomonas  an  update

Pseudomonas PNA

Dr.T.V.Rao MD 52

Page 53: Pseudomonas  an  update

Ecthyma Gangrenosum• Ecthyma gangrenosum is a well

recognized cutaneous manifestation of severe, invasive infection by Pseudomonas aeruginosa that is usually seen in immunocompromised, burn patients, and other critically ill patients

Dr.T.V.Rao MD 53

Page 54: Pseudomonas  an  update

Echtyma Gangrenosum

Dr.T.V.Rao MD 54

Page 55: Pseudomonas  an  update

Malignant Otitis Externa

Dr.T.V.Rao MD 55

Page 56: Pseudomonas  an  update

Pseudomonas Keratitis and Corneal Ulceration

Dr.T.V.Rao MD 56

Page 57: Pseudomonas  an  update

Endocarditis

Dr.T.V.Rao MD 57

Page 58: Pseudomonas  an  update

Cystic fibrosis• Most common life-threatening

inherited genetic disorder in the Caucasian population

• Mutation in the cystic fibrosis trans membrane conductance regulator (CFTR) gene

• one in every 25 carry the mutated recessive gene and more than 1 in 4000 live births suffer from CF.

• Dr.T.V.Rao MD 58

Page 59: Pseudomonas  an  update

Chronic infection of the Cystic Fibrosis lung

Dr.T.V.Rao MD 59

Page 60: Pseudomonas  an  update

Pseudomonas and urinary tract infections

Dr.T.V.Rao MD 60

• Pseudomonal UTIs are usually hospital-acquired and are associated with catheterization, instrumentation, and surgery. These infections can involve the urinary tract through an ascending infection or through bacteriuic spread. In addition, these infections are a frequent source of bacteraemia. No specific characteristics distinguish this type of infection from other forms of UTI.

Page 61: Pseudomonas  an  update

Diagnosis of P.aeroginosa infection

Dr.T.V.Rao MD 61

• Diagnosis of P,aeroginosa infection depends upon isolation and laboratory identification of the bacterium. It grows well on most laboratory media and commonly is isolated on blood agar or eosin-methylthionine blue agar. It is identified on the basis of its Gram morphology, inability to ferment lactose, a positive oxidase reaction, its fruity odour, and its ability to grow at 42°C. Fluorescence under ultraviolet light is helpful in early identification of P.s aeruginosa colonies. Fluorescence is also used to suggest the presence of P. aeruginosa in wounds.

Page 62: Pseudomonas  an  update

Fluorescence of Pseudomonas• Fluorescence under

ultraviolet light is helpful in early identification of P.s aeruginosa colonies. Fluorescence is also used to suggest the presence of P. aeruginosa in wounds.

Dr.T.V.Rao MD 62

Page 63: Pseudomonas  an  update

Diagnosis of P. aeruginosa

• Isolation and lab identification of the pathogen• P. aeruginosa grows well on most laboratory media • Identified on the basis of its:

– Gram morphology, – inability to ferment lactose, – a positive oxidase reaction, – its characteristic odor, – its ability to grow at 42° C. – Fluorescence is helpful in early identification of P.

aeruginosa colonies and may also help identify its presence in wounds.

Dr.T.V.Rao MD 63

Page 64: Pseudomonas  an  update

What antibiotics to use

Dr.T.V.Rao MD 64

• Aminoglycosides• Gentamycin, Amikacin,

Cephalosporins • Cefotaxime. Ceftazidime. Ofloxacin,• Piperacillin, Ticarcillin• Local application, colistin,

polymyxin

Page 65: Pseudomonas  an  update

Treating pseudomonas infections

Dr.T.V.Rao MD 65

• Combined antibiotic therapy is generally required to avoid resistance that develops rapidly when single drugs are employed. Avoid using inappropriate broad-spectrum antibiotics, which can suppress the normal flora and permit overgrowth of resistant pseudomonads.

Page 66: Pseudomonas  an  update

Treatment of P. aeruginosa infections

• P. aeruginosa is frequently resistant to many commonly used antibiotics.

• To archive synergy a combination of e.g. gentamicin and carbenicillin is frequently used.

• No vaccines so far

Dr.T.V.Rao MD 66

Page 67: Pseudomonas  an  update

Pseudomonas aeruginosa a resistant pathogen

Dr.T.V.Rao MD 67

• Pseudomonas aeruginosa is frequently resistant to many commonly used antibiotics. Although many strains are susceptible to gentamicin, tobramycin, colistin, and amikacin, resistant forms have developed. The combination of gentamicin and carbenicillin is frequently used to treat severe Pseudomonas infections. Several types of vaccines are being tested, but none is currently available for general use.

Page 68: Pseudomonas  an  update

Antibiotic Resistance• Inherently resistant to many antibiotics• Can mutate to more resistant strains

during therapy• Penetration of abx highly dependent on

outer membrane pores which can be altered

• Production of B-lactamases• Combination of active antibiotics

generally required for successful therapy

Dr.T.V.Rao MD 68

Page 69: Pseudomonas  an  update

P. aeruginosaPrevention and Control

Pseudomonas spp. normally inhabit soil, water, and vegetation and can be isolated from the skin, throat, and stool of healthy persons.

Spread is mainly via contaminated sterile equipment's and cross-contamination of patients by medical personnel.

Dr.T.V.Rao MD 69

Page 70: Pseudomonas  an  update

Prevention and Control

• High risk population: patients receiving broad-spectrum antibiotics, with leukaemia, burns, cystic fibrosis, and immunosuppression.

• Methods for control of infection are similar to those for other nosocomial pathogens. Special attention should be paid to sinks, water baths, showers, hot tubs, and other wet areas.Dr.T.V.Rao MD 70

Page 71: Pseudomonas  an  update

BURKHOLDERIA• Although most of the

presently 30 known Burkholderia species are saprophytes, B. pseudomallei, B. mallei and the B. cepacia complex are important human or animal pathogens

Dr.T.V.Rao MD 71

Page 72: Pseudomonas  an  update

Burkholderia pseudomallei

• Burkholderia pseudomallei is the causative agent of melioidosis, a serious tropical infection of man and animals endemic in South-East Asia and Northern Australia

Dr.T.V.Rao MD 72

Page 73: Pseudomonas  an  update

B. pseudomallei • The environmental saprophyte

B. pseudomallei causes melioidosis, a life-threatening tropical infection of man and animals in Southeast Asia and Northern Australia. In endemic areas the organism is found in soil and surface water, particularly rice paddy fields and monsoon drains. Isolation rates are highest during the rainy season and in still rather than flowing water.

Dr.T.V.Rao MD 73

Page 74: Pseudomonas  an  update

Other related organisms • A closely related species, B. mallei,

causes glanders, a potentially fatal infectious disease of horses, mules and donkeys. Laboratory-acquired infection with either organism is a serious risk (hazard category 3) and both are regarded as potential bioterrorism agents.

Dr.T.V.Rao MD 74

Page 75: Pseudomonas  an  update

B. cepacia• B. cepacia, the cause of

soft rot of onions, is also an important human pathogen causing life-threatening respiratory infection in immunocompromised patients, particularly those treated in intensive care or with chronic granulomatous disease. Dr.T.V.Rao MD 75

Page 76: Pseudomonas  an  update

B.cepacia and Cystic fibrosis

• In cystic fibrosis, anxiety over B. cepacia is based on the innate multiresistance of the organism to antibiotics, its transmissibility by social contact, and the risk of cepacia syndrome, an acute, fatal necrotizing pneumonia, sometimes accompanied by bacteraemia, which occurs in 20-30% of infected patients.

Dr.T.V.Rao MD 76

Page 77: Pseudomonas  an  update

Virulence factors in B.cepacia

• B. cepacia complex isolates produce several putative virulence determinants, including proteases, catalases, haemolysin, exopolysaccharide, cable pili and other adhesins. In vitro the lipid A of these bacteria stimulates pro-inflammatory cytokines tenfold more than Ps. aeruginosa lipid A.

Dr.T.V.Rao MD 77

Page 78: Pseudomonas  an  update

Pathogenesis• Human infection is acquired mainly

percutaneously through skin abrasions or by inhalation of contaminated particles, especially during monsoon rains. Melioidosis commonly presents as pyrexia. The clinical manifestations are protean and range from dormant subclinical infection,.

Dr.T.V.Rao MD 78

Page 79: Pseudomonas  an  update

Diagnosis • Diagnosed by the presence of specific

antibodies, to acute pneumonia or chronic pulmonary infection that may resemble tuberculosis and other conditions, leading to a fulminating septicaemia with a mortality rate of 80-90%.. Suppurative parotitis is a characteristic presentation of melioidosis in children

Dr.T.V.Rao MD 79

Page 80: Pseudomonas  an  update

Treatment • Accurate and early diagnosis, including

culture of B. pseudomallei, and appropriate antibiotic therapy are key to successful management. The optimum treatment of severe melioidosis is unclear. Intravenous ceftazidime, followed by a combination of co-trimoxazole and doxycycline, is emerging as the treatment of choice.

Dr.T.V.Rao MD 80

Page 81: Pseudomonas  an  update

Treatment is a Urgent Concern

• Intravenous ceftazidime, followed by a combination of co-trimoxazole and doxycycline, is emerging as the treatment of choice. Imipenem or meropenem have sometimes been effective when treatment with ceftazidime has proved unsuccessful. Prolonged treatment is necessary to avoid relapse

Dr.T.V.Rao MD 81

Page 82: Pseudomonas  an  update

Dr.T.V.Rao MD 82

• Programme Created by Dr.T.V.Rao MD for Medical and Paramedical Students

in Developing World• Email

[email protected]